生命科学资讯

Diagonal banks another $125M for ‘clustering’ antibody drugs

Former Genentech leaders’ protein degrader startup EpiBiologics nets $107M

EpiBiologics raises $107M for its protein-degrading cancer drug

CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria

Illumina turns up the power with new research platform - Business Weekly

Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News

Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News

How The Narrative Around Thermo Fisher Scientific (TMO) Is Shifting After Q3 And New Forecasts - Yahoo Finance

Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT - The Malaysian Reserve

A Look At 10x Genomics (TXG) Valuation After The New ImmuneScape Partnership Announcement - simplywall.st

WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities

Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M

Pupil dilation offers a time-window on prediction error

Phase-specific premotor inhibition modulates leech rhythmic motor output

Cross-species evaluation of TANGO2 homologs, including HRG-9 and HRG-10 in Caenorhabditis elegans, challenges a proposed role in heme trafficking

Dissecting surveying behavior of reactive microglia under chronic neurodegeneration

Barcode activity in a recurrent network model of the hippocampus enables efficient memory binding

Reconstructing voice identity from noninvasive auditory cortex recordings

Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs

Lilly to pay $1.2B for Ventyx and its NLRP3 drugs